已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Seasonal and geographic variation in cutaneous immune‐related adverse events after treatment with immune checkpoint inhibitors

医学 中毒性表皮坏死松解 皮疹 不利影响 银屑病 队列 癌症 彭布罗利珠单抗 皮肤病科 肿瘤科 免疫疗法 内科学
作者
Ahmad Rajeh,Katie Roster,Kerry L. Reynolds,Nicole R. LeBoeuf,Ryan J. Sullivan,Shawn G. Kwatra,Yevgeniy R. Semenov
出处
标识
DOI:10.1111/jdv.20484
摘要

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. Up to 40% of patients receiving ICI treatment develop cutaneous immune-related adverse events (cirAEs),1 which may server as prognostic indicators of therapeutic response.2, 3 Identifying cirAE risk factors can thus help stratify ICI candidates at the highest risk of toxicity and shed light on immune response mechanisms during ICI treatment. This study aims to investigate the seasonal and regional variability in cirAE development using a multi-centre cohort of ICI recipients. We used the TriNetX Dataworks Network, which provides deidentified data on over 90 million US patients. Cancer patients who received ICI therapy between January 2010 and December 2019 were selected. To identify cirAEs, we compiled a list of International Classification of Diseases 10th Revision (ICD-10) codes corresponding to potential ICI-induced cutaneous toxicities, informed by existing literature and expert consensus.4 New diagnoses such as psoriasis, rash, vitiligo, drug hypersensitivity, eczema, erythema multiforme, Stevens–Johnson syndrome, toxic epidermal necrolysis, lichen planus, bullous dermatosis and pruritus were considered cirAEs if they occurred more than once after ICI initiation. Diagnoses were excluded if recorded ≥2 times within 6 months before ICI initiation or within 3 months of a chemotherapy. We built competing risks Fine–Gray and Prais–Winsten regression models to test the association between cirAE risk and the season of ICI initiation, controlling for age, sex, race and ethnicity, ICI target, ICI year, cancer type, regional variation and autocorrelation expected in time series data. The ICI cohort comprised 15,253 patients between January 2010 and December 2019, of whom 2413 patients (15.8%) developed cirAEs. The rate of cirAEs was highest in the fall (43%), followed by the spring (21%), winter (19%) and summer (17%) seasons. Using competing risks and Prais–Winsten models, the risk of cirAE was significantly associated with starting ICI in the winter (β, 0.006; 95% CI, 0.001–0.012, p = 0.013) (Table 1). This seasonality was robust to sensitivity analysis after excluding all diagnoses of eczema which often flares in the winter (β, 0.005; 95% CI, 0.003–0.008, p < 0.001). Analysis of geographic variation in cirAE development in the United States revealed the highest rate in the West (35%), followed by the South (29%), Northeast (21%) and Midwest (16%). Multivariate competing risks analysis showed significantly increased risk of cirAE development in the west (HR, 2.42; 95% CI, 2.18–2.68; p < 0.001), while there was decreased cirAE risk in the northeast (HR, 0.87; 95% CI, 0.77–0.99; p = 0.029) (Figure 1). Overall, cirAE incidence varied by season, with peak incidence in fall and a heightened risk associated with patients initiating ICI treatment in winter. It is possible that these trends align with variations in pathogen exposure. For example, cold viruses such as respiratory syncytial virus and human metapneumovirus are more prevalent during these seasons, potentially contributing to immune dysregulation and cirAE susceptibility.5 Additionally, decreased vitamin D exposure during winter, and seasonal fluctuations in CD4 T-cell expansion and regulatory T-cell levels, could partially explain these patterns.6 Similarly, geographic variation in pathogen landscapes and vitamin D exposure may influence immune responses and contribute to cirAE pathogenesis. This study highlights seasonal and regional variability in cirAE development, suggesting the importance of incorporating temporal considerations into risk assessment, surveillance and management. Future work needs to similarly explore large-scale seasonal and geographic patterns in patient survival after ICI, as recent work demonstrates seasonality in outcomes after ICI treatment for BRAF wild-type melanoma living in Denmark.7 Limitations of this study include its retrospective design, the broad region definitions in TriNetX to preserve deidentification and the use of ICD-10 codes to identify cirAEs which limits the identification of some uncoded cutaneous eruptions, although this approach previously showed an accuracy of 87%.4 YRS is supported by the Department of Defense, under award number W81XWH2110819, by the Dermatology Foundation and the National Institute of Health K23AR080791-01A1. The authors have no conflicts of interest to declare. This study utilized de-identified data from a multi-institutional registry and was deemed exempt from Institutional Review Board review, as it did not involve human subjects research or the collection of identifiable patient information. The data that support the findings of this study are available from the corresponding author upon reasonable request.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷你的夜天完成签到 ,获得积分10
1秒前
积极的板栗完成签到 ,获得积分10
2秒前
Manzia完成签到,获得积分10
2秒前
dwx0529完成签到,获得积分10
3秒前
李健应助xiaomu采纳,获得10
3秒前
悟格完成签到,获得积分10
5秒前
Liangyong_Fu完成签到 ,获得积分10
6秒前
满眼星辰完成签到 ,获得积分10
7秒前
万能图书馆应助Grandir采纳,获得20
7秒前
榴莲姑娘完成签到 ,获得积分10
7秒前
yema完成签到 ,获得积分10
8秒前
姜sir完成签到 ,获得积分10
8秒前
吴谷杂粮完成签到 ,获得积分10
8秒前
nater3ver完成签到,获得积分10
8秒前
Snow完成签到 ,获得积分10
9秒前
11秒前
等等完成签到 ,获得积分10
12秒前
小二郎应助直觉采纳,获得10
12秒前
ColinWine完成签到 ,获得积分10
13秒前
13秒前
爆米花应助song采纳,获得10
14秒前
Weiyu完成签到 ,获得积分10
14秒前
加油杨完成签到 ,获得积分10
14秒前
XL神放发布了新的文献求助10
14秒前
lvsehx完成签到,获得积分10
15秒前
闪闪的谷梦完成签到 ,获得积分10
18秒前
HS完成签到,获得积分10
18秒前
彩色的荔枝完成签到 ,获得积分10
18秒前
雪白的凡灵完成签到,获得积分10
19秒前
蔡翌文完成签到 ,获得积分10
19秒前
陌路完成签到 ,获得积分10
20秒前
甘sir完成签到 ,获得积分10
20秒前
跳跃楼房完成签到 ,获得积分10
22秒前
河鲸完成签到 ,获得积分10
22秒前
xwwx完成签到 ,获得积分10
23秒前
cqhecq完成签到,获得积分10
23秒前
晚意完成签到 ,获得积分10
24秒前
24秒前
25秒前
三个气的大门完成签到 ,获得积分10
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989949
求助须知:如何正确求助?哪些是违规求助? 3532017
关于积分的说明 11255865
捐赠科研通 3270829
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882233
科研通“疑难数据库(出版商)”最低求助积分说明 809216